Synthorx Investors

15 investors on Angel Roster list Synthorx in their portfolio. Most are venture capital firms and university program investors, the most common stage is Series A and the largest groups are based in the United States and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Synthorx can appear together.

Investors listed
15
With verified email
80%
Most common stage
Series A
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 15 Synthorx investors

The most complete profiles first. Showing 15 of 15.

  • Jay LichterVerified

    Venture Capital, Investor · United States

    Series AAdvertisingHealth CareData IntegrationHospitals

    Portfolio: Talla, NanoNets, Node, Enlibrium and 58 more

    Verified email available

  • Jon EdwardsVerified

    Venture Capital, Investor · United States

    SeedHealth CareHospitalsWomen FoundedEnergy

    Portfolio: Rondo Therapeutics, Gadeta, SuperX, Critical Pressure and 24 more

    Verified email available

  • Kevin KinsellaVerified

    Venture Capital, Founder, Angel/Individual · United States

    Series AAdvertisingHealth CareData IntegrationHospitals

    Portfolio: Talla, NanoNets, Node, Enlibrium and 57 more

    Verified email available

  • Louis BernemanVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Manny StockmanVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Richard LeeVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    SeedHealth CareHospitalsE-commerceWomen Founded

    Portfolio: Gadeta, SuperX, Critical Pressure, Impact Biomedicines and 23 more

    Verified email available

  • Robert AdelsonVerified

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 65 more

    Verified email available

  • Anurag AgarwalVerified

    Venture Capital, University Program, Entrepreneurship Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • David GraingerVerified

    Venture Capital · United Kingdom

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: Gadeta, SuperX, Critical Pressure, Impact Biomedicines and 23 more

    Verified email available

  • Matt CohenVerified

    Venture Capital, University Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Verified email available

  • Shyam M.Verified

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: Gadeta, SuperX, Critical Pressure, Impact Biomedicines and 23 more

    Verified email available

  • Marc Singer

    Venture Capital, University Program, Entrepreneurship Program · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 69 more

    Contact details available

  • William Harrington

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more

    Contact details available

  • Andrew LevinVerified

    Venture Capital, Angel/Individual · United States

    Portfolio: Delix Therapeutics, Synthorx, Arvinas, Alchemab Therapeutics and 3 more

    Verified email available

  • Kirsten Leute

    Venture Capital, University Program · United States

    Health CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Synthorx investors are on Angel Roster?

Angel Roster lists 15 Synthorx investors. 12 of them (80%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (15), University Program Investors (8) and Private Equity Firms (6). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Synthorx investors invest in?

Among those that list a stage, the most common are Series A (7) and Seed (2).

Where are Synthorx investors based?

Most are based in the United States (12) and the United Kingdom (3).

Which companies have Synthorx investors backed?

The most-backed portfolio companies among them are Capella BioScience (12), Palladio Biosciences (12), Fortis Therapeutics (10), Everactive (8) and Picwell (8).

How do I contact Synthorx investors?

Create a free Angel Roster account to search and filter all 15, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.